Grand River Aseptic Manufacturing (GRAM), a parenteral contract development and manufacturing organization (CDMO), has appointed Bernie King as chief operating officer, a new position within GRAM. King will report to Tom Ross, president and CEO of GRAM.
 
“GRAM has grown rapidly since 2010, and even more rapidly in the past two years as we brought on a world-class aseptic filling facility and state-of-the-art finishing center. Facility expansions, advanced technology, and experiences gained manufacturing COVID vaccines and fighting a pandemic all strategically brought GRAM to a new level,” said Ross. “Bernie’s executive-level experience in operations, supply chain, and manufacturing make him a perfect fit as GRAM’s chief operating officer. I look forward to all he will accomplish with our team.”
 
As COO, King will assist in the evolution of the GRAM organization as new technology and capacity are added at their industry-leading facilities. Additionally, he will continue to build GRAM’s talent and team of experts to best serve client and industry demands.
 
“I am extremely excited to join the GRAM team as we enter a stage of significant growth and potential. GRAM is rapidly establishing itself as a premier supplier among CDMO’s. Our ongoing investment in world-class facilities and talent will enable GRAM to provide our clients with the highest level of service as they continue to bring life-saving products to market. I’m honored to now be part of that mission,” said King.
 
King’s previous experience includes vice president roles at Merck & Co, Wyeth, Pfizer, and Sanofi Pasteur. He brings in-depth expertise leading manufacturing and site operations, global supply chain management, and strategic planning to his new role at GRAM. King is a manufacturing and supply chain management executive with a proven track record maximizing operational performance.